In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
about
Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up.Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.Hepatocellular carcinoma and the underlying mechanisms.Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.Persistent expression of hepatitis C virus non-structural proteins leads to increased autophagy and mitochondrial injury in human hepatoma cells.Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected GambiansEthanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal.Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury.Cytogenetic methods for detection of oxidative stress and evaluation of antioxidant therapy in hepatitis C infection.Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.Oxidized proteins and their contribution to redox homeostasis.Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study.Hepatitis C virus-induced mitochondrial dysfunctions.Real time in vivo investigation of superoxide dynamics in zebrafish liver using a single-fiber fluorescent probe.Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis.Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells.Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C.Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species.Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy.Role of free radicals in liver diseases.The role of liver biopsy in detection of hepatic oxidative stress.Effect of extractions from Ephedra sinica Stapf on hyperlipidemia in mice.Clastogenic factors as potential biomarkers of increased superoxide productionEfficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.Development of an animal model of chronic alcohol-induced pancreatitis in the rat.Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.Hepatitis C Virus-Associated Cancers.Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis.Nigella sativa attenuates myocardial ischemic reperfusion injury in rats.Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.Lipid profiling of pre-treatment liver biopsy tissue predicts sustained virological response in patients with chronic hepatitis C.Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis.Ethylenediaminetetraacetic acid induces antioxidant and anti-inflammatory activities in experimental liver fibrosis.
P2860
Q31898205-2A19F8B4-DCFA-40AD-9633-CA8F0D2DFF0AQ33894202-06E41204-FD05-4939-9859-716B5F127A14Q33956158-83B71CE8-027A-40C9-B002-EEC84AA8B06AQ34075939-0AAED43A-5D8D-489D-83AA-EACC21E546B7Q34099283-D549A88C-8A4C-4801-AA02-7217CF44ED6DQ34174489-D8FDBD70-F9D3-45D3-B510-5903E5AEFA51Q34206982-486587F7-4B8D-4FFD-8E4A-10B3D35ED163Q34207274-C6B1251E-7B2E-4664-9A87-0A91058BB2A4Q35540270-DFFEAE37-5F4C-4A6F-9329-75192089AB89Q35598407-16CEC0D3-DC6F-412E-8294-5C6C91EB557DQ36046406-5C28807A-445F-453A-A588-A2EEB3382246Q36301722-CCC5FF66-353B-4620-B0DA-F8514B1E60CFQ36581068-B1AF8C3C-BD9D-400C-8D32-03385501D242Q36993948-440E505E-0745-4977-9342-0AC73345761CQ37167719-30C68DAA-9968-4C2C-9058-C66DDBE3294BQ37207336-D0D6217E-5BB0-4B77-8C5F-808903DE42C4Q37238469-E351B8E4-1AC7-4437-B219-AFD4EBF7D13FQ37627117-E4C04C19-C137-4A4F-A4BA-6C92CCA42B2BQ39349474-8EB13130-8F70-4D04-9240-7DFC49D6C672Q40707274-5FB1E8EF-BDDF-4E76-9672-7F3E79669B31Q40757681-F56080E5-D133-48F5-A027-1B5837F5C33AQ41879333-9C2ABE39-EB4C-43A7-B071-1AFD76F1BA78Q41983643-AECD4D7B-68A9-4783-832A-A6273A136469Q42001692-1E5F8369-7FCC-46D1-9F2E-CB2919115D86Q42004029-C95CA378-55A7-4222-A8FD-7DA44DAE9BB3Q42008127-488CFFAF-7C20-46D7-BDE6-BA0C52153CE4Q43040192-27C4633A-AAC8-425D-9602-DF8646D2CE1AQ43040452-9E715B19-6B93-4EEB-88F4-5FEA7EBC0EF7Q43607592-C969FC77-51BD-4100-BD2B-395CB09BB7BAQ44009612-7F4ADBE7-7087-4F0F-A9EC-EBB70859CC6BQ45325989-B422CD44-EA88-4F54-8BCA-BDD2102EF0A2Q46343410-EE084A42-1029-468B-9A42-0D27A0DC95E2Q46383086-2A9B847E-91A0-4B69-8BA7-1ADFFDE2B584Q46709785-1ACDD324-A8C2-40EA-A43A-AD2AE66F47C0Q50551920-93767335-2C88-4D6A-ACF1-5D7B4C085DDCQ51747614-A296A2A2-1B81-45A4-98AB-810EAEF2A3EBQ54361709-5420BC25-47AF-4AB7-9071-1183DC5FA367
P2860
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In situ detection of lipid per ...... on with pathological features.
@en
In situ detection of lipid per ...... on with pathological features.
@nl
type
label
In situ detection of lipid per ...... on with pathological features.
@en
In situ detection of lipid per ...... on with pathological features.
@nl
prefLabel
In situ detection of lipid per ...... on with pathological features.
@en
In situ detection of lipid per ...... on with pathological features.
@nl
P2093
P2860
P50
P356
P1476
In situ detection of lipid per ...... on with pathological features.
@en
P2093
A Holstege
F Charlotte
F Imbert-Bismut
M Kollinger
P2860
P304
P356
10.1136/JCP.50.5.401
P407
P577
1997-05-01T00:00:00Z